Common Injectable Cycle Patterns Approach Conservative start Daily dose 1.0 mg Schedule 5 days on / 2 off Cycle length 4 weeks Approach Standard Daily dose 1.0-1.5 mg Schedule Daily Cycle length 4-6 weeks Approach Higher end Daily dose 1.5-2.0 mg Schedule Daily Cycle length 6-8 weeks Educational reference
GHK-Cu is often compared with BPC-157, TB-500, and KPV
Our blended peptide formulations expertly combine two or more high-purity peptides in precise proportions, delivering balanced, synergistic, and scientifically robust solutions
Product Specifications Test Results Sample: DSIP 5mg Certificate of Analysis Certificates of Analysis Third-party tested for ~99% purity DSIP Properties Source: PubChem Form: Lyophilized powder Unit size: 5mg/vial Unit quantity: 1 vial Molecular formula: C 35 H 48 N 10 O 15 Molecular weight: 848.8 g/mol Synonym: Emideltide, Delta sleep-inducing peptide Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu CAS number: 62568-57-4 Frequently Asked Questions Related Products 3 of 45 products KPV (10mg) PNC-27 (10mg) How It Works Precision Synthesis Synthesized in dedicated, state of-the-art facilities
For GHK-Cu, the best-supported claims come from topical and wound-related evidence, while injectable and systemic claims need more rigorous human data [2], [3], [8]
K.S.B., S.M.A., O.G.-Q., and J.S.A
